Presented at Thessaloniki 2024 - Panel: Advancing Global Prevention Initiatives: Standardization, Innovation & Cultural Adaptation, on the 27th of June, 2024.
Background There is little research on lifetime trauma exposure among individuals undergoing medication treatment for opioid use disorder (MOUD). A multisite study examined the prevalence of lifetime trauma and explored differences based on...
Background: Limited research has been conducted on lifetime trauma exposure among individuals undergoing medication treatment for opioid use disorder (MOUD). A multisite study provided an opportunity to investigate the prevalence of...
Background: Since 1996, an urban community-based organization has been providing screening, testing, overdose prevention, referrals, and access to treatment for substance use disorders (SUD) and communicable diseases such as HIV through its...
Background: Many people with substance use disorders undergoing opioid agonist therapy often have physical or mental health commorbidities. Exercise is recognised as beneficial for both prevention and treatment of various health conditions...
There is little study of lifetime trauma exposure among individuals engaged in medication treatment for opioid use disorder (MOUD). A multisite study provided the opportunity to examine the prevalence of lifetime trauma and differences by gender, PTSD status, and chronic pain.
Ahsania Mission Female Drug Treatment Center is celebrating its 10th anniversary a significant achievement for women with substance use disorders The number of female substance users has been increasing alarmingly, but they are lagging...
Specific patterns of substance use have been found to correlate with an elevated risk of suicidal thoughts, attempts, and mortality by suicide. However, this relationship is multifaceted and influenced by various intersecting factors...